The Recall Desk
Agency classClass IIOur severity:SevereFDA (Devices)·Z-0844-2013·Announced 2013-02-27

Codman NeuroPath Guiding Catheters Recalled for Potential Sterility Compromise

Codman & Shurtleff is recalling 56 NeuroPath 6Fx90 Guiding Catheters because package integrity issues may compromise device sterility.

The agency’s classification

FDA (Devices): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, and the potential loss of sterility in an intravascular device poses a significant risk of serious injury or infection, meeting the criteria for a Severe rating.

Plain-English summary

Codman & Shurtleff, Inc. is recalling 56 units of the NEUROPATH 6Fx90 GUIDING CATH HH (Product Code: GHH60900000). The recall is being conducted because the sterility of the device may be compromised due to a lack of package integrity. These medical devices are intended for use in the coronary, peripheral, and neurovasculature for the intravascular introduction of interventional and diagnostic devices.

The affected units were distributed worldwide, including nationwide in the United States and internationally to Austria, Belgium, Canada, Chile, Costa Rica, Czech Republic, Denmark, France, Germany, Great Britain/UK, Ireland, Italy, Lithuania, Malaysia, Netherlands, New Zealand, Norway, Poland, Portugal, Singapore, Slovakia, Spain, and Switzerland. The recall covers all unexpired lots of the product.

Healthcare providers and facilities that have received these devices should stop using them and contact Codman & Shurtleff, Inc. for further instructions on the return or disposal of the affected units.

The recalled product

Product
NEUROPATH 6Fx90 GUIDING CATH HH Product Code: GHH60900000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices
Affected units
56

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All unexpired lots

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 24 recalled by Codman & Shurtleff, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 24 products in this recall →

Similar recalls